Cite
Prognostic gene expression signature for high-grade serous ovarian cancer
MLA
Millstein, J., et al. Prognostic Gene Expression Signature for High-Grade Serous Ovarian Cancer. Sept. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..af2ade2cd37beaef06d324cec9ddbdab&authtype=sso&custid=ns315887.
APA
Millstein, J., Budden, T., Goode, E., Anglesio, M., Talhouk, A., Intermaggio, M., Leong, H., Chen, S., Elatre, W., Gilks, B., Nazeran, T., Volchek, M., Bentley, R., Wang, C., Chiu, D., Kommoss, S., Leung, S., Senz, J., Lum, A., … Chang-Claude, J. (2020). Prognostic gene expression signature for high-grade serous ovarian cancer.
Chicago
Millstein, J, T Budden, El Goode, Ms Anglesio, A Talhouk, Mp Intermaggio, Hs Leong, et al. 2020. “Prognostic Gene Expression Signature for High-Grade Serous Ovarian Cancer,” September. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..af2ade2cd37beaef06d324cec9ddbdab&authtype=sso&custid=ns315887.